Search results
AbbVie (ABBV) Laps the Stock Market: Here's Why
Zacks via Yahoo Finance· 1 day agoFor comparison, its industry has an average Forward P/E of 14.5, which means AbbVie is trading at a premium to the group. Also, we should mention that...
AbbVie Inc. (NYSE:ABBV) Shares Acquired by Cullen Capital Management LLC
ETF DAILY NEWS· 14 hours agoCullen Capital Management LLC lifted its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 7.2% during the fourth quarter, according to the company in its most ...
Sei Investments Co. Buys 25,042 Shares of AbbVie Inc. (NYSE:ABBV)
ETF DAILY NEWS· 1 day agoSei Investments Co. raised its holdings in AbbVie Inc. (NYSE:ABBV – Free Report) by 5.7% during the 4th quarter, Holdings Channel.com reports. The institutional investor owned ...
AbbVie’s RINVOQ now indicated for paediatric arthritis in US
Pharmaceutical Technology via Yahoo Finance· 7 days agoIn May 2024, the European Medicines Agency’s Committee for Medicinal Products for Human Use granted ...
AbbVie, Amazon, Goldman Sachs And 2 Major Health Care Stocks On CNBC's 'Final Trades' - AbbVie...
Benzinga· 4 days agoAbbVie Inc. has good dividend yield and attractive valuations, according to Jim Lebenthal of Cerity...
AbbVie's tight grip on Humira market raises concerns about biosimilars
Reuters via Yahoo News· 5 days agoAbbVie’s top-selling arthritis drug Humira has held onto more than 80% of patients after facing nine...
2 High-Yield Dividend Stocks to Buy Right Now | The Motley Fool
The Motley Fool· 6 days agoDividend stocks are sensitive to interest rates. When rates fall, studies show that money managers...
Biotech Blockbusters: 3 Pharma Stocks to Buy in June for Breakthrough Potential
InvestorPlace via Yahoo Finance· 6 days agoThe biotech sector has been through a lot in the past five years and it is finally rebounding. One...
AbbVie's Arthritis Drug Humira Retains Market Dominance Despite Biosimilar Competition, Challenges...
Benzinga· 4 days agoAbbVie Inc’s ABBV top-selling arthritis drug, Humira, has managed to retain over 80% of its patients even after facing nine lower-priced rivals in the U.S. over the past year ...
Pharma Stock Roundup: LLY's CFO Departs, ABBV, AZN Drugs Get CHMP Approval
Zacks via Yahoo Finance· 4 days agoAbbVie has also submitted an application to the FDA, seeking approval for Skyrizi for the UC...
